Bead-based multiplexed immunoassays to identify new biomarkers in maternal serum to improve first trimester Down syndrome screening

Prenatal Diagnosis

Volumn 29, Issue 9, 2009, Pages 857-862

  Koster, M P H ^a,b   Pennings, J L A ^a   Imholz, S ^a   Rodenburg, W ^a   Visser, G H A ^b   De Vries, A ^a   Schielen, P C J I ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Bead based multiplexed immunoassays; Biomarkers; Down syndrome; First trimester; Proteomics

Indexed keywords

BIOLOGICAL MARKER; CHORIONIC GONADOTROPIN BETA SUBUNIT; PLASMA PROTEIN;

ADULT; ARTICLE; BEAD BASED MULTIPLEXED IMMUNOASSAY; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOWN SYNDROME; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; IMMUNOASSAY; MATERNAL SERUM; NUCHAL TRANSLUCENCY MEASUREMENT; PLASMA; PRENATAL SCREENING; PRIORITY JOURNAL; PROTEIN ANALYSIS;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DOWN SYNDROME; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; IMMUNOASSAY; MASS SCREENING; MICROSPHERES; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PRENATAL DIAGNOSIS;

EID: 69749098657     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.2294     Document Type: Article

References (28)

1. Bocconi L, Nava S, Fogliani R, Nicolini U. 1997. Trisomy 21 is associated with hypercholesterolemia during intrauterine life. Am J Obstet Gynecol 176(3): 540-543. (Pubitemid 27147158)
2. Brackenridge CJ, Pitt DB. 1976. An anomaly in the inheritance of haptoglobin types in Down's syndrome: a study of mother-child pairs. Clin Genet 9(5): 459-462.
3. Busch A, Michel S, Hoppe C, Driesch D, Claussen U, von Eggeling F. 2005. Proteome analysis of maternal serum samples for trisomy 21 pregnancies using ProteinChip arrays and bioinformatics. J Histochem Cytochem 53(3): 341-343. (Pubitemid 40344070)
4. Crossley JA, Aitken DA, Cameron AD, McBride E, Connor JM. 2002. Combined ultrasound and biochemical screening for Down's syndrome in the first trimester: a Scottish multicentre study. BJOG 109(6): 667-676. (Pubitemid 37329279)
5. Cuadrado E, Barrena MJ. 1996. Immune dysfunction in Down's syndrome: primary immune deficiency or early senescence of the immune system? Clin Immunol Immunopathol 78(3): 209-214. (Pubitemid 26127983)
6. Cuckle H, Benn P, Wright D. 2005. Down syndrome screening in the first and/or second trimester: model predicted performance using meta-analysis parameters. Semin Perinatol 29(4): 252-257. (Pubitemid 41133566)
7. Cuckle HS, Wald NJ, Thompson SG. 1987. Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha-fetoprotein level. Br J Obstet Gynaecol 94(5): 387-402.
8. Debieve F, Moiset A, Thomas K, Pampfer S, Hubinont C. 2001. Vascular endothelial growth factor and placenta growth factor concentrations in Down's syndrome and control pregnancies. Mol Hum Reprod 7(8): 765-770. (Pubitemid 32734300)
9. Eddleman KA, Malone FD, Sullivan L, et al. 2006. Pregnancy loss rates after midtrimester amniocentesis. Obstet Gynecol 108(5): 1067-1072. (Pubitemid 44665399)
10. Fan HC, Blumenfeld YJ, Chitkara U, Hudgins L, Quake SR. 2008. Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc Natl Acad Sci U S A 105(42): 16266-16271.
11. Go AT, Visser A, Mulders MA, Blankenstein MA, van Vugt JM, Oudejans CB. 2007. 44 single-nucleotide polymorphisms expressed by placental RNA: assessment for use in noninvasive prenatal diagnosis of trisomy 21. Clin Chem 53(12): 2223-2224. (Pubitemid 350197315)
12. Hedley P, Christiansen M. 2008. Serum leptin in first-trimester Down syndrome pregnancies. Prenat Diagn 28(6): 475-477. (Pubitemid 351946947)
13. Kolialexi A, Tsangaris GT, Papantoniou N, et al. 2008. Application of proteomics for the identification of differentially expressed protein markers for Down syndrome in maternal plasma. Prenat Diagn 28(8): 691-698.
14. Laigaard J, Sørensen T, Fröhlich C, et al. 2003. ADAM12: a novel first-trimester maternal serum marker for Down syndrome. Prenat Diagn 23(13): 1086-1091. (Pubitemid 38084153)
15. Lo YM. 2000. Fetal DNA in maternal plasma. Ann N Y Acad Sci 906: 141-147.
16. Moll SJ, Jones CJ, Crocker IP, Baker PN, Heazell AE. 2007. Epidermal growth factor rescues trophoblast apoptosis induced by reactive oxygen species. Apoptosis 12(9): 1611-1622.
17. Myrick JE, Caudill SP, Hubert IL, Robinson MK, Adams MJ Jr, Pueschel SM 1990. Identification of haptoglobin alpha-2FF variants in mid-trimester maternal serum as potential markers for Down syndrome. Appl Theor Electrophor 1(5): 233-241.
18. Nagalla SR, Canick JA, Jacob T, et al. 2007. Proteomic analysis of maternal serum in down syndrome: identification of novel protein biomarkers. J Proteome Res 6(4): 1245-1257. (Pubitemid 46724021)
19. Nespoli L, Burgio GR, Ugazio AG, Maccario R. 1993. Immunological features of Down's syndrome: a review. J Intellect Disabil Res 37: 543-551. (Pubitemid 23362851)
20. Odibo AO, Gray DL, Dicke JM, Stamilio DM, Macones GA, Crane JP. 2008. Revisiting the fetal loss rate after second-trimester genetic amniocentesis: a single center's 16-year experience. Obstet Gynecol 111(3): 589-595.
21. Palomaki GE, Neveux LM, Donnenfeld A, et al. 2008. Quality assessment of routine nuchal translucency measurements: a North American laboratory perspective. Genet Med 10(2): 131-138. (Pubitemid 351271725)
22. Pidoux G, Guibourdenche J, Frendo JL, et al. 2004. Impact of trisomy 21 on human trophoblast behaviour and hormonal function. Placenta 25(Suppl A): S79-S84. (Pubitemid 38514961)
23. R Development Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing: Vienna. ISBN 3-900051-07-0, URL http://www.R-project.org.
24. Schielen PC, van Leeuwen-Spruijt M, Belmouden I, Elvers LH, Jonker M, Loeber JG. 2006. Multi-centre first-trimester screening for Down syndrome in the Netherlands in routine clinical practice. Prenat Diagn 26(8): 711-718. (Pubitemid 44252249)
25. Tsangaris GT, Karamessinis P, Kolialexi A, et al. 2006. Proteomic analysis of amniotic fluid in pregnancies with Down syndrome. Proteomics 6(15): 4410-4419. (Pubitemid 44277042)
26. Van Lith JM, Beekhuis JR, Van Loon AJ, Mantingh A, De Wolf BT, Breed AS. 1991. Alpha-fetoprotein in fetal serum, amniotic fluid, and maternal serum. Prenat Diagn 11(8): 625-628.
27. Wright D, Spencer K, Nix B. 2007. First trimester screening for Down syndrome using free beta hCG, total hCG and PAPP-A: an exploratory study. Prenat Diagn 27(12): 1118-1122. (Pubitemid 350250586)
28. Wright A, Zhou Y, Weier JF, et al. 2004. Trisomy 21 is associated with variable defects in cytotrophoblast differentiation along the invasive pathway. Am J Med Genet A 130A(4): 354-364. (Pubitemid 39441610)